| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP CLO & General Counsel | EVP Legal & General Counsel | EVP & General Counsel +3 more
1 company
Patrick R. O'Neil is EVP CLO & General Counsel at IONS. From January 2019 to August 2026, the filings on record show 0 open-market purchases and 31 sales. Patrick R. O'Neil's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.4M at current prices.
Historically, Patrick R. O'Neil's trades have earned a middling insider score of 63/100 across 26 rated trades. Over a 12-month horizon, 59.1% of those trades were profitable, with an average 12-month return of -9.2%.
The IONS filings lean toward selling, a net 463,394 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | IONS Ionis Pharmaceuticals Inc | EVP CLO & General Counsel | Sell10b5-1 | 1,207 | $32.35 | $39,046.45 | -2.1% | +2.5% | +154.4% | |
| Feb 4, 2025 | IONS Ionis Pharmaceuticals Inc | EVP CLO & General Counsel | Sell10b5-1 | 6,165 | $31.62 | $194,939.15 | -9.7% | +6.3% | +168.6% | |
| Jan 31, 2025 | IONS Ionis Pharmaceuticals Inc | EVP CLO & General Counsel | Sell | 1,406 | $32.49 | $45,684.60 | -2.2% | -0.6% | +159.2% | |
| Jan 16, 2025 | IONS Ionis Pharmaceuticals Inc | EVP CLO & General Counsel | Sale+OE | 7,360 | $32.83 | $241,628.80 | -10.7% | -12.2% | +136.5% | |
| Feb 2, 2024 | IONS Ionis Pharmaceuticals Inc | EVP CLO & General Counsel | Sell | 1,961 | $49.67 | $97,410.32 | -3.9% | -13.4% | -35.9% | |
| Jan 25, 2024 | IONS Ionis Pharmaceuticals Inc | EVP CLO & General Counsel | Sell10b5-1 | 6,450 | $51.75 | $333,787.50 | -12.1% | -17.7% | -32.6% | |
| Jan 17, 2024 | IONS Ionis Pharmaceuticals Inc | EVP CLO & General Counsel | Sale+OE | 7,744 | $50.42 | $390,429.25 | -12.7% | -19.0% | -37.1% | |
| Dec 26, 2023 | IONS Ionis Pharmaceuticals Inc | EVP CLO & General Counsel | Sale+OE10b5-1 | 20,825 | $51.46 | $1,071,716.98 | -34.0% | -14.4% | -29.2% | |
| May 24, 2023 | IONS Ionis Pharmaceuticals Inc | EVP CLO & General Counsel | Sell10b5-1 | 1,527 | $41.70 | $63,675.90 | -3.6% | -4.7% | -7.9% | |
| Feb 6, 2023 | IONS Ionis Pharmaceuticals Inc | EVP CLO & General Counsel | Sell | 1,920 | $40.86 | $78,460.42 | -4.4% | -13.1% | +21.3% |